ArticleMolecular and cellular biochemistry2026
Effects of LATS1/2 kinases inhibition on lung epithelial cells in a regeneration model.
Article in Molecular and cellular biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Research focused on studying Hippo signaling up- and downregulation in a model of mouse lung cell regeneration. The cell-specific role of the activation and inhibition of Hippo signaling is demonstrated at the cellular level within the context of a unified bronchoalveolar lung organoid model. We used pharmacological modulators of Hippo pathway components-TRULI and verteporfin. The findings revealed that inhibition of Lats1/2 kinases via TRULI leads to different levels of Hippo gene expression for different lung cell types. The inhibition of Lats1/2 kinases enhances cell proliferation in the bronchiolar epithelium, while verteporfin suppresses it. However, no changes in the cellular composition of the bronchiolar epithelium (except ciliated cells) were observed with either TRULI or verteporfin. Inhibition of Lats1/2 kinases in the alveolar epithelium leads to a decrease in type 2 alveolocytes and alters their differentiation trajectories. The results demonstrate a cell-specific influence of Hippo modulation on the lung cells and may prove useful for the development of novel therapeutic approaches for the treatment of respiratory pathologies.
Indexed as
Identifiers
42319713What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.